NCT06756828View on ClinicalTrials.gov

Effects of 3-Month Melatonin Treatment on Regional Cerebellar Structure and Blood Biomarkers in Alzheimer's Disease Spectrum

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 15, 2025

Primary Completion Date

August 30, 2026

Study Completion Date

December 30, 2026

Conditions
ElderlyAlzheimer DiseaseMelatoninCognitive DeclineBiomarker with Neurodegeneration PatientsCerebellum
Interventions
DRUG

Melatonin

3months melatonin

BEHAVIORAL

Cognitive behavioral therapy group for insomnia

15minutes of sleep hygiene education on the first day of visiting the hospital

All Listed Sponsors
lead

Saint Vincent's Hospital, Korea

OTHER

NCT06756828 - Effects of 3-Month Melatonin Treatment on Regional Cerebellar Structure and Blood Biomarkers in Alzheimer's Disease Spectrum | Biotech Hunter | Biotech Hunter